Introduction: Stroke is one of the leading causes of death in Romania. Evidence in supporting the role of the pro-infl ammatory cytokine TNFalpha in ischemic pathogenesis is now well established. The aim of the present study is to evaluate the relationship between TNF -308G>A polymorphism and ischemic stroke in a Northern Romanian population group and to determine whether it has an infl uence on the risk of cerebral events. This is a cross-sectional, randomized, case-control study for the evaluation of TNF -308G>A polymorphism alleles frequency among patients with ischemic stroke. Material and method: The study included 108 patients diagnosed with ischemic stroke (neurological and CT scan examination), and 118 healthy unrelated controls. TNF -308G>A genotyping was carried out using PCR-RFLP technique. The amplifi cation of the relevant gene fragment was subjected to restriction enzyme digestion, followed by gel electrophoresis. Results: Molecular analysis did not reveal an increased frequency of GA mutant genotype in the study group compared to the control group (p = 0.879, OR = 0.928, CI = 0.512-1.682).
Introduction
Ischemic stroke is one of the major public health issues, accounting for one in four causes of death in Europe [1, 2] . Th e CARDIO-Zone study showed that general prevalence of stroke and its risk factors in Romania is high, with no signifi cant diff erences regarding risk factors compared to EU countries [3] .
Ischemic stroke has a genetic basis and it is considered a multifactorial disorder [4, 5] . Stroke is diffi cult to study from a molecular point of view, because of its gene-environment interactions, genetic and nongenetic heterogeneity, polygenic inheritance with variable penetrance and not least, late age of onset [6] . Candidate genes, stroke susceptibility alleles and their association with stroke pathogeny have been intensely studied in the last few years [7, 8, 9] . Immunity and infl ammation are key elements of the pathobiology of ischemic stroke [10] , several studies have shown that the serum of patients with stroke highlights increased levels of proinfl ammatory cytokines, and therefore support the hypothesis promoting their involvement in the etiopathogenesis of the disease [11, 12] . Th e TNF gene is located on chromosome 6 (p21.3) and is one of the most potent proinfl ammatory cytokines with both benefi cial and negative properties for the central nervous system [13, 14] . Tumour necrosis factor alpha (TNF-) and its receptors are normally expressed in the brain, animal studies have already shown that proinfl ammatory cytokines like IL-1 and TNF- are related with the Shwartzman phenomenon (induced cytokine vulnerability of blood vessels) and therefore stroke [15] . Functional polymorphisms in the promoter region of the TNF gene (G to A substitution in the -308 position) is associated with increased plasma levels of this cytokine [16] , therefore the potential role of this genetic variant in stroke etiophatogenesis [17, 18] .
Th e aim of our study was to investigate the association between TNF -308G>A gene polymorphism and the risk of ischemic stroke in a Romanian population group.
Material and method
Th is cross-sectional, randomized case-control study involved 108 patients diagnosed with ischemic stroke and 118 unrelated controls.
Th e study was approved by the Ethics Commitee of the "Iuliu Hațieganu" University of Medicine and Pharmacy of Cluj Napoca, and all participants were provided a written informed consent. Diagnosis was confi rmed following neurological assessment and CT scan evaluation in all cases. A sample of 3 ml EDTA venous blood was collected from all patients and controls.
Genotyping (adapted after Ishii T et al. 2000) [19] DNA was extracted from 300 μl peripheral blood samples using Wizard Genomic DNA Purifi cation Kit (Wizard® Genomic DNA Purifi cation Kit, Promega, MA, USA).
Correspondence to: Felicia Petrișor E-mail: genetica.umfcj@gmail.com Th e TNF -308G>A polymorphism was detected using a PCR-RFLP method. Th e PCR primers (Eurogentec, Belgium) are described as follows:
For the specifi c genetic analysis, a total amount of 100 ng of genomic DNA was amplifi ed in a total volume of 25 μl reaction mixture (Th ermo Fischer Scientifi c Inc., MA, USA) containing reaction buff er of 1.5 nM MgCl 2 , 20 pmol of each primer, 200 μm of each dNTPs and 0.5 units of Taq polymerase.
PCR was carried out using a commercial thermal cycler (Eppendorf Mastercycler Th ermal Cycler). Th e amplifi cation steps consisted of an initial 12 minutes denaturation at 95 °C, followed by 35 cycles of denaturation at 95 °C for 30 seconds each, primer annealing at 60 °C for 30 seconds, primer elongation at 72 °C for 1 minute and a 5 minutes fi nal elongation at 72 °C.
Th e PCR amplifi cation products were digested overnight with 5 units of NcoI enzyme (Th ermo Fischer Scientifi c Inc., MA, USA); the resulted fragments were then separated on a 3 % agarose gel (MetaPhor® Agarose, Cambrex Bio Science Inc.) and transilluminated with UV light. Electrophoretic analysis defi nes 3 distinct banding patterns, each corresponding for 3 possible genotypes: A1A1 wild type homozygous genotype (326 and 36 bp fragments), A1A2 heterozygous genotype (362, 326 and 36 bp fragments) and A2A2 mutant homozygous genotype (362 bp undigested fragment).
Statistical analysis
For statistical analysis we used SPSS 18.0 for Windows. (SPSS, Inc., Chicago, IL). P value and Odds ratio (OR) assessment with 95% confi dence limits were calculated by logistic regression.
Results
Th ere was no statistically signifi cant diff erence in mean age and gender distribution between the cases and controls. (Table I) .
Th e AA genotype was not detected in any of the subjects, probably because of the decreased number of AA carriers in the population, since the A allele is very rare, therefore a more accurate statistical analysis using the Fisher comparative analysis according dominant and recessive model could not be performed.
Discussions
Ischemic stroke is a multifactorial disorder with a strong genetic component. Th e pathophysiology of stroke implies several diff erent pathways, like lipid metabolism, coagulation, systemic chronic infl ammation, blood pressure regulation, and cellular adhesion, therefore candidate gene polymorphisms in these pathways have been proposed as genetic risk factors and consequently studied in few medical studies [20, 21] .
Tumor necrosis factor-alpha (TNF) is a cytokine with diverse proinfl ammatory actions, including endothelial leukocyte adhesion molecule expression; the neuronal expression of TNF seems to facilitate the infi ltration of infl ammatory cells in cerebral ischemia and might contribute to increased sensitivity and risk in ischemic stroke [22] .
Comparative analysis of TNF -308G>A polymorphism did not reveal a statistically increased frequency of mutant allele in the study group compared to the controls. Our results come in agreement with relevant data highlighted in other studies that indicated no correlations be- tween TNF and stroke [23, 24, 25] . Other studies contradict the results mentioned above, revealing a connection between TNF polymorphisms and stroke. One of these studies highlights the protective role of TNF in ischemic stroke [26] , while another study performed in the USA, places the same polymorphisms in the group of genetic risk factors for stroke [27] . Although there is increased evidence about the role of proinfl amatory cytokines such as TNF and stroke etiopathogenesis, the results of our study failed to demonstrate this hypothesis. We found no association between the distribution of variant -308G>A alleles among patients diagnosed with stroke compared to controls.
TNF levels are elevated in essential hypertension, supporting the fact that hypertension is in part an infl ammatory disorder [28] . Several studies [29, 30] revealed a link between TNF polymorphisms and pregnancy associated hypertension, placing the characteristic female hormonal profi le among the risk factors for stroke, nevertheless no statistically signifi cant associations were observed among mutant carrier patients and controls regarding the sex and associated pathology (systemic hypertension), probably because of the more complex etiopathogenesis of this multifactorial disease.
Conclusions
Th e results of our study reveals no association between TNF -308G> genetic polymorphism and ischemic stroke. Th e complex etiology of stroke suggests that individual genetic polymorphisms have modest eff ects that are diffi cult to detect, as has been observed to date, therefore larger studies are needed to assess these genetic polymorphisms as risk factors.
